Drug donations to Bosnia-Hercegovina are often inappropriateBMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7063.1011b (Published 19 October 1996) Cite this as: BMJ 1996;313:1011
- Maurizio Bonati, Head,
- Gilles B Forte, Adviser,
- Kees DE Joncheere, Regional adviser for pharmaceuticals,
- Einar Magnusson, Director
- Laboratory for Mother and Child Health, Istituto di Ricerche Farmacologiche Mario Negri, 20157 Milan, Italy
- Programme for Pharmaceuticals, World Health Organisation, Regional Office for Europe, DK-2100 Copenhagen, Denmark
- Pharmaceutical Affairs, Ministry of Health and Social Security, IS-150 Reykjavik, Iceland
EDITOR,—The programme for pharmaceuticals of the World Health Organisation's Regional Office for Europe recently carried out a situation analysis of the pharmaceuticals in Bosnia-Hercegovina. One striking finding was the large amount of unused drugs that originated from donations. This finding is not exclusive to Bosnia-Hercegovina, and urgent action is needed to prevent such situations in countries in transition.
In Bosnia-Hercegovina 70–80% of drugs were reported to have been provided by humanitarian organisations, charities, and groups of …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial